- Home
- ZLAB vs APAM Comparison
ZLAB vs APAM Comparison
Compare ZLAB & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- APAM
- Stock Information
- Founded
- ZLAB 2013
- APAM 1994
- Country
- ZLAB China
- APAM United States
- Employees
- ZLAB N/A
- APAM N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- APAM Investment Managers
- Sector
- ZLAB Health Care
- APAM Finance
- Exchange
- ZLAB Nasdaq
- APAM Nasdaq
- Market Cap
- ZLAB 3.6B
- APAM 2.9B
- IPO Year
- ZLAB 2017
- APAM 2013
- Fundamental
- Price
- ZLAB $29.76
- APAM $39.74
- Analyst Decision
- ZLAB Buy
- APAM Hold
- Analyst Count
- ZLAB 4
- APAM 5
- Target Price
- ZLAB $47.37
- APAM $39.50
- AVG Volume (30 Days)
- ZLAB 944.8K
- APAM 593.0K
- Earning Date
- ZLAB 05-08-2025
- APAM 07-22-2025
- Dividend Yield
- ZLAB N/A
- APAM 8.81%
- EPS Growth
- ZLAB N/A
- APAM 10.09
- EPS
- ZLAB N/A
- APAM 3.64
- Revenue
- ZLAB $418,326,000.00
- APAM $1,124,598,000.00
- Revenue This Year
- ZLAB $44.07
- APAM $3.53
- Revenue Next Year
- ZLAB $49.13
- APAM $5.21
- P/E Ratio
- ZLAB N/A
- APAM $11.08
- Revenue Growth
- ZLAB 43.72
- APAM 11.90
- 52 Week Low
- ZLAB $16.01
- APAM $32.75
- 52 Week High
- ZLAB $39.77
- APAM $49.54
- Technical
- Relative Strength Index (RSI)
- ZLAB 44.77
- APAM 45.21
- Support Level
- ZLAB $30.11
- APAM $40.27
- Resistance Level
- ZLAB $31.34
- APAM $41.56
- Average True Range (ATR)
- ZLAB 1.06
- APAM 0.86
- MACD
- ZLAB -0.02
- APAM -0.40
- Stochastic Oscillator
- ZLAB 36.04
- APAM 0.52
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.